Pharma IQ Members

Business Development

Are you a service provider to the pharma/bio industry? Find out the invaluable steps you can take to develop your business. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in business development and marketing to exchange ideas on best practice and share case studies on business development, strategy, advertising and marketing for the pharmaceutical, biotechnology and healthcare sectors.

205 results
of 19
Contributor: Pharma IQ News
Posted: 20/06/2017
Pharma IQ News
The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10. Full Content »
Contributor: Pharma IQ
Posted: 13/06/2017
Pharma IQ
Despite the volume of deals dipping, pharma companies paid a lot more for mergers and acquisitions in 2016. The FT reports that the value of deals increased by almost double. Full Content »
Contributor: Ash Rishi
Posted: 18/04/2017
Ash Rishi
Patient education is an important factor in disease self-management, and when handled properly it has been found to have a significant, positive impact on improving patient outcomes. Full Content »
Contributor: Pharma IQ
Posted: 31/03/2017
Pharma IQ
Here are some of the key M&A transactions and partnerships that took place in 2016. Full Content »
Contributor: Pharma IQ News
Posted: 31/03/2017
Pharma IQ News
Pharma IQ brings you a round up of the latest developments within the Pharma and Biotech industries. Full Content »
Contributor: Pharma IQ
Posted: 29/03/2017
Pharma IQ
As the term patient centricity continues to buzz in the pharma industry, data has emerged stating that US physicians have experienced an overwhelming amount of confusion from patients around direct to consumer (DTC) adverts. Full Content »
Posted: 10/04/2017
What is Pharma IQ?Pharma IQ is the leading online resource hub for the global pharmaceutical professionals who have exclusive access to a library of resources including news, trends, reports, whitepapers, videos, webinars and more. Our community of members includes over 100,000 senior level pharmaceutical professionals and decision-makers. By Full Content »
Contributor: Pharma IQ
Posted: 14/02/2017
Pharma IQ
We spoke to CRISPR experts Robin Ketteler and Lorena Benedetti to find out about their work within CRISPR, insights on where the technique is heading and the field’s exciting developments. Full Content »
Contributor: Social Monsters.org
Posted: 14/02/2017
default profile icon
After years of resistance, the health care and pharmaceutical industries are now accelerating full steam towards the cloud. In fact, the global health care cloud computing market, valued at $4.5 billion in 2016, will reach $9.5 billion by 2020. Here are the dominant benefits that are drawing these giants to the cloud. Full Content »
Contributor: Ash Rishi
Posted: 07/02/2017
Ash Rishi
When it comes to manoeuvrability and nimble response, large companies have more in common with ocean liners than speedboats. Policies are agreed, marketing strategies planned, and future developments or projects set in motion months or years in advance. Full Content »
Posted: 06/02/2017
Pharma IQ
One healthcare official told me yesterday, 'Yes, drug prices need to come down. At the same time, though, we do need to ensure that pharma companies do keep the incentive to innovate.' And I've got the boss of one of the biggest healthcare companies in the world sitting right next to me, that's Joe Jimenez the CEO of Novartis. Full Content »
205 results
of 19